Another contributing factor to the high IR of lymphoma observed in our study may include a large number of claims for thymus and activation‐regulated chemokine (TARC) tests in patients from Japan with AD and comorbid lymphoma. This evidence concerns the gene CCL17 and Alzheimer disease.